Impact of staged InterStim® implantation on the postoperative activities of daily living and pain
- First Online:
- Cite this article as:
- Kawasaki, A., Judd, J.P., Siddiqui, N.Y. et al. Int Urogynecol J (2013) 24: 1205. doi:10.1007/s00192-012-1965-y
- 157 Downloads
To evaluate the short-term effects of staged InterStim® implantation on activities of daily living (ADL) and pain.
This prospective study assessed women undergoing staged InterStim® implantation. The Older Americans Resources and Services Program Multidimensional Functional Assessment Questionnaire asked participants about their ability to complete activities without help or what help they needed following stage I lead placement and stage II neurostimulator implantation. Narcotic use and a visual analog scale (VAS) for pain were recorded daily.
Thirty-eight women underwent stage I with 33 (86.8 %) progressing to stage II. On stage I postoperative day (POD) 2, more women required help shopping compared with baseline (40 vs 17 %, p < 0.004). The median pain score increased on Stage I POD1 (P < 0.001) and the use of narcotics increased on POD1 and 2 compared with baseline (50 % vs 14 %, p = 0.001). The same trends were seen following stage II.
Staged InterStim® implantation has minimal impact on ADL, pain or narcotic requirements.